The Gross Margin of ScinoPharm Taiwan Ltd (1789.TW) is 38.17%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 38.17% |
2023-12-31 | 38.17% |
2022-12-31 | 38.32% |
2021-12-31 | 46.36% |
2020-12-31 | 42.73% |
2019-12-31 | 40.67% |
2018-12-31 | 43.77% |
2017-12-31 | 44.08% |
2016-12-31 | 44.80% |
2015-12-31 | 42.39% |